Australia - English - Department of Health (Therapeutic Goods Administration)

medical specialties australasia pty ltd - 47535 - varicose vein lasing procedure kit - endovascular coagulation of the great saphenous vein (gsv) in patients with superficial vein reflux, for the treatment of varicose veins and varicosities associated with superficial reflux of the gsv and for the treatment of incompetence and reflux of the superficial veins of the lower extremity.

Australia - English - Department of Health (Therapeutic Goods Administration)

arico corporation pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

arico corporation pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

arico corporation pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

regional health care group pty ltd - 47535 - varicose vein lasing procedure kit - the elves? kit is intended to provide necessary equipment for the placement of the endovenous laser occlusion catheter in patients with venous insufficiency. the procedures are suited to the following anatomical structures: great saphenous, small saphenous, accessory veins, perforating veins (leg). the kit contains, guidewire, entry needles, vessel dilator, introducer radial fibre

Australia - English - Department of Health (Therapeutic Goods Administration)

biolitec australia pty ltd - 47535 - varicose vein lasing procedure kit - elves plus kits and elves radial kits are intended for use in endovascular occlusion of the greater saphenous vein and smaller saphenous vein in patients with superficial vein reflux. this is a single-use device.

Australia - English - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

thermo fisher scientific australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

evergrowth pty ltd - ginkgo biloba, quantity: 50 mg (equivalent: ginkgo biloba, qty 2.5 g; equivalent: ginkgolides and bilobalide, qty 3 mg; equivalent: ginkgo flavonglycosides, qty 12 mg) - tablet, film coated - excipient ingredients: hypromellose; colloidal anhydrous silica; povidone; macrogol 400; calcium hydrogen phosphate dihydrate; magnesium stearate; microcrystalline cellulose; crospovidone; carnauba wax - antioxidant/reduce free radicals formed in the body ; maintain/support healthy hearing ; maintain/support general health and wellbeing ; maintain/support healthy blood circulation ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support blood capillary health ; decrease/reduce/relieve aching/tired legs/leg heaviness associated with mild varicose veins ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase mental alertness/wakefulness ; maintain/support memory/mental recall

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - lauromacrogol 400, quantity: 60 mg - injection, solution - excipient ingredients: ethanol; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; water for injections - indications: the solutions are indicated for the treatment of varicose veins (up to 6mm diameter) of the lower limbs by compression sclerotherapy.